Nanotechnology-based solutions may be employed for diagnostics of SARS-CoV-2 infection and for treatment of COVID-19.

Remdesivir and Molnupiravir belong to what class of therapeutic agents?

Nanomaterials may be used in what aspects of the prevention of SARS-CoV-2 infection and management of COVID-19:

Nucleoside analogues work by blocking the replication of SARS-CoV-2 genome.

Conservative management of symptomatic COVID-19 is based on:

Leave a Reply